B.1.1.529 variant named Omicron, designated as a Variant of concern (VOC) by WHO

WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) was convened on 26th November 2021 to assess the variant B.1.1.529. Based on the available evidences, the group of experts has advised WHO that this variant should be designated as a Variant of concern (VOC), and named Omicron. 

The B.1.1.529 variant was first reported to WHO from South Africa on 24th November 2021. The first known confirmed B.1.1.529 infection was from a specimen collected on 9th November 2021. Since then, the number of COVID-19 cases has steeply increased in almost all provinces in South Africa. This variant is characterised by a large number of mutations. Apparently, there is an increased risk of reinfection with this variant, as compared to others.  

Hence, based on the available evidences, the expert group has advised WHO that this variant should be designated as a VOC, and named Omicron. 

A variant of concern (VOC) is a variant of interest (VOI) that has shown an increase in transmissibility and/or virulence and/or decrease in effectiveness of public health measures at a degree of global public health significance: 

Individuals are reminded to take appropriate COVID-19 measures to reduce their risk of disease, including proven public health and social measures such as wearing well-fitting masks, hand hygiene, physical distancing, improving ventilation of indoor spaces, avoiding crowded spaces, and getting vaccinated. 

 *** 

Source:  

WHO 2021. News – Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Published 26 November 2021. Available online at https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern  

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

PROBA-V Completes 7 years in the Orbit Serving Humankind

The Belgian satellite PROBA-V, developed by European Space Agency...

HEROES: A Charity Founded by NHS Workers to Help NHS Workers

Founded by NHS workers to help NHS workers, has...

Food Wastage Due to Premature Discarding: A Low-cost Sensor to Test Freshness

Scientists have developed an inexpensive sensor using PEGS technology...

The MOP3 session to combat illicit Tobacco trade concludes with Panama Declaration

Third session of the Meeting of the Parties (MOP3)...

James Webb’s Ultra Deep Field Observations: Two Research Teams to Study Earliest Galaxies  

James Webb Space Telescope (JWST), the space observatory designed...

Decline in Sense of Smell May be Early Sign of Health Deterioration Among Elderly

A long follow up cohort study shows that loss...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...